These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7391983)

  • 21. Drug uptake in a rodent sarcoma model after intravenous injection or isolated lung perfusion of free/liposomal doxorubicin.
    Cheng C; Haouala A; Krueger T; Mithieux F; Perentes JY; Peters S; Decosterd LA; Ris HB
    Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):635-8. PubMed ID: 19282323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes.
    Mayhew E; Rustum YM; Szoka F; Papahadjopoulos D
    Cancer Treat Rep; 1979; 63(11-12):1923-8. PubMed ID: 526925
    [No Abstract]   [Full Text] [Related]  

  • 24. Teratogenesis and inhibition of DNA synthesis induced in rat embryos by cytosine arabinoside.
    Ritter EJ; Scott WJ; Wilson JG
    Teratology; 1971 Feb; 4(1):7-13. PubMed ID: 5541179
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
    Dadashzadeh S; Vali AM; Rezaie M
    Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and organ distribution of liposome-encapsulated L-carnitine in rats.
    Jäger W; Koch HP
    Arzneimittelforschung; 1993 Sep; 43(9):974-7. PubMed ID: 8240461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target-sensitive immunoliposomes as an efficient drug carrier for antiviral activity.
    Ho RJ; Rouse BT; Huang L
    J Biol Chem; 1987 Oct; 262(29):13973-8. PubMed ID: 2820987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of CPX-351 (cytarabine/daunorubicin HCl) liposome injection in the mouse.
    Bayne WF; Mayer LD; Swenson CE
    J Pharm Sci; 2009 Jul; 98(7):2540-8. PubMed ID: 19009594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of liposome encapsulation on paclitaxel developmental toxicity in the rat.
    Scialli AR; Waterhouse TB; Desesso JM; Rahman A; Goeringer GC
    Teratology; 1997 Nov; 56(5):305-10. PubMed ID: 9451754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of HVJ-liposome mediated gene transfer in lung transplantation-distribution and transfection efficiency in the lung.
    Ohmori K; Takeda S; Miyoshi S; Minami M; Nakane S; Ohta M; Sawa Y; Matsuda H
    Eur J Cardiothorac Surg; 2005 May; 27(5):768-73. PubMed ID: 15848312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
    Beland FA
    Res Rep Health Eff Inst; 1995 Oct; (72):1-27; discussion 29-39. PubMed ID: 11381742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating carrier erythrocytes: slow-release vehicle for an antileukemic drug, cytosine arabinoside.
    DeLoach JR; Barton C
    Am J Vet Res; 1982 Dec; 43(12):2210-2. PubMed ID: 7165167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the tissue distribution of liposome-associated clofazimine, an antileprosy drug.
    Sritharan M
    Methods Find Exp Clin Pharmacol; 1993 Mar; 15(2):107-11. PubMed ID: 8487593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acceleration of the excretion of monomeric 239Pu-citrate from the body as effected by pentacyne encapsulated in liposomes].
    Il'in LA; Smirnov AA; Ivannikov AT; Parfenova IM
    Vopr Med Khim; 1983; 29(4):109-12. PubMed ID: 6353751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes.
    Williams SS; Alosco TR; Mayhew E; Lasic DD; Martin FJ; Bankert RB
    Cancer Res; 1993 Sep; 53(17):3964-7. PubMed ID: 8358724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary investigation of the nasal delivery of liposomal leuprorelin acetate for contraception in rats.
    Shahiwala A; Misra A
    J Pharm Pharmacol; 2006 Jan; 58(1):19-26. PubMed ID: 16393460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
    Gabizon A; Catane R; Uziely B; Kaufman B; Safra T; Cohen R; Martin F; Huang A; Barenholz Y
    Cancer Res; 1994 Feb; 54(4):987-92. PubMed ID: 8313389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99): comparison with doxorubicin and empty liposomes in mice and dogs.
    Kanter PM; Bullard GA; Pilkiewicz FG; Mayer LD; Cullis PR; Pavelic ZP
    In Vivo; 1993; 7(1):85-95. PubMed ID: 8504212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Free versus liposome-entrapped streptomycin sulfate in treatment of infections caused by Salmonella enteritidis.
    Khalil RM; Murad FE; Yehia SA; El-Ridy MS; Salama HA
    Pharmazie; 1996 Mar; 51(3):182-4. PubMed ID: 8900871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [(IgG)2 protein A]2 complex stimulates cytosine arabinoside incorporation into DNA and inhibits L cell proliferation.
    Shearer WT; Green CG; Gilliam EB; Langone JJ
    Immunopharmacology; 1984 Oct; 8(2):103-10. PubMed ID: 6511365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.